Related Experiment Video
Updated: Jun 23, 2026
06:13
Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
[Preoperative corticosteroid treatment and nasal polyposis]
J Giordano1, J Darras, D Chevalier
1Service d'ORL et de chirurgie cervico-faciale, hôpital C. Huriez, CHRU de Lille, Place de Verdun, 59000 Lille, France.
Summary
Preoperative systemic corticosteroids did not reduce bleeding during endoscopic ethmoidectomy for chronic rhinosinusitis with nasal polyps (CRSwNP). However, the procedure duration was shorter, potentially improving surgical conditions by reducing inflammation.
Area of Science:
- Otolaryngology
- Surgical Innovation
- Medical Research
Background:
- Bleeding during endoscopic ethmoidectomy for chronic rhinosinusitis with nasal polyps (CRSwNP) can compromise surgical view and increase risks.
- Improving surgical field quality is crucial for patient safety and procedural success.
Purpose of the Study:
- To evaluate the impact of a short course of systemic corticosteroid treatment on intraoperative bleeding and surgical field quality.
- To assess the effect of preoperative prednisolone on endoscopic ethmoidectomy outcomes in CRSwNP patients.
Main Methods:
- A prospective study involving 40 CRSwNP patients undergoing endoscopic ethmoidectomy.
- 21 patients received 7 days of 1 mg/kg/day prednisolone pre-surgery (group B); 19 did not (group A).
- Comparison of intraoperative blood loss, surgery duration, and endoscopic grading between groups.
Main Results:
- No statistically significant difference in intraoperative blood loss between groups.
- Surgical procedure duration was significantly shorter in the prednisolone group (72 min vs. 85 min, p=0.05).
- Lund-Mackay CT scores were higher in the prednisolone group (19/24 vs. 21/24, p=0.05).
Conclusions:
- Preoperative systemic corticosteroids do not appear to reduce surgical blood loss in this context.
- A reduction in procedure duration was observed, suggesting improved surgical efficiency.
- Corticosteroid treatment may reduce mucosal inflammation, potentially aiding surgical eradication and improving local conditions.
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:30Epistaxis
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...